Showing results (2371-2380 of 3,008) with videos related to
Sort By:
Pageof 301
Journal of Advanced Research|November 3, 2024
Genetic associations of metabolic factors and therapeutic drug targets with polycystic ovary syndromeChanglong Zhang, Yuxuan Li, Yang Wang, et al.Journal of Advanced Research|October 16, 2024
Ecological consequences of antimicrobial residues and bioactive chemicals on antimicrobial resistance in agroecosystemsMuhammad Shafiq, Charles Obinwanne Okoye, Mudasir Nazar, et al.Journal of Advanced Research|October 14, 2024
Food inflammation index reveals the key inflammatory components in foods and heterogeneity within food groups: How do we choose food?Zhangtie Wang, Changzheng Yuan, Yansong Zhang, et al.Journal of Advanced Research|October 3, 2024
Unravelling the role of WRKY transcription factors in leaf senescence: Genetic and molecular insightsZishan Ahmad, Muthusamy Ramakrishnan, Chunyue Wang, et al.Journal of Advanced Research|October 23, 2024
Contribution of Pseudomonas aeruginosa - mediated club cell necroptosis to the bias of type 17 inflammation and steroid insensitivity in asthmaJieying Guan, Wenruo Yao, Le Zhang, et al.Journal of Advanced Research|October 1, 2024
Salidroside sensitizes Triple-negative breast cancer to ferroptosis by SCD1-mediated lipogenesis and NCOA4-mediated ferritinophagyGuiqin Huang, Yawen Cai, Menghui Ren, et al.Journal of Advanced Research|September 15, 2024
Developing Patient-Derived 3D-Bioprinting models of pancreatic cancerHang Sun, Yan Wang, Minghao Sun, et al.Journal of Advanced Research|November 3, 2024
Small-molecule targeting BCAT1-mediated BCAA metabolism inhibits the activation of SHOC2-RAS-ERK to induce apoptosis of Triple-negative breast cancer cellsLing Huang, Guanjun Li, Ying Zhang, et al.Journal of Advanced Research|November 3, 2024
Impaired stemness in aging periodontal ligament stem cells is mediated by the progerin/endoplasmic reticulum stress/p53 axisXige Zhang, Yazheng Wang, Jinjin Wang, et al.Journal of Advanced Research|September 10, 2024
Rationally designed BCR-ABL kinase inhibitors for improved leukemia treatment via covalent and pro-/dual-drug targeting strategiesJie Sun, Liang Lou, Chengjun Zhu, et al.Pageof 301